Home > > > > > Report Detail

Global Ankylosing Spondylitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 26-Dec-2023
No. of pages: 110

Market Overview of Global Ankylosing Spondylitis market:

According to our latest research, the global Ankylosing Spondylitis market looks promising in the next 5 years. As of 2022, the global Ankylosing Spondylitis market was estimated at USD 5633.32 million, and it's anticipated to reach USD 9003.47 million in 2028, with a CAGR of 8.13% during the forecast years.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ankylosing Spondylitis market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Ankylosing Spondylitis Market Report:

Market Size Estimates: Ankylosing Spondylitis market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Ankylosing Spondylitis market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Ankylosing Spondylitis market

Segment Market Analysis: Ankylosing Spondylitis market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Ankylosing Spondylitis market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Ankylosing Spondylitis Market: Revenue and sales volume of major countries in each region

Ankylosing Spondylitis Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Ankylosing Spondylitis market in major regions.

Ankylosing Spondylitis Industry Value Chain: Ankylosing Spondylitis market raw materials & suppliers, manufacturing process, distributors, downstream customers

Ankylosing Spondylitis Industry News, Policies & Regulations

Key players in the global Ankylosing Spondylitis market are covered in Chapter 12:

Shanghai Pharmaceuticals

Pfizer

Abbvie

UCB

Eisai

Celgene

Regeneron Pharmaceuticals

Merck & Co.

Merck Sharp & Dohme

Novartis

Celltrion

Sanofi

Bristol-Myers Squibb

Janssen Pharmaceuticals

Otsuka Pharmaceutical

F. Hoffmann-La Roche

Amgen

Boehringer Ingelheim

In Chapter 2 and Chapter 15.1, based on types, the Ankylosing Spondylitis market from 2018 to 2028 is primarily split into:

TNF Inhibitors

COX Inhibitors

Others

In Chapter 3 and Chapter 15.2, based on applications, the Ankylosing Spondylitis market from 2018 to 2028 covers:

Oral

Parenteral

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Ankylosing Spondylitis market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Ankylosing Spondylitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Ankylosing Spondylitis Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Ankylosing Spondylitis Market Size (2018-2028)
1.3.1 Global Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Ankylosing Spondylitis Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Ankylosing Spondylitis Historic Revenue ($) by Type (2018-2023)
2.2 Global Ankylosing Spondylitis Historic Sales Volume by Type (2018-2023)
2.3 TNF Inhibitors Sales and Price (2018-2023)
2.4 COX Inhibitors Sales and Price (2018-2023)
2.5 Others Sales and Price (2018-2023)

3 Global Ankylosing Spondylitis Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Ankylosing Spondylitis Historic Revenue ($) by Application (2018-2023)
3.2 Global Ankylosing Spondylitis Historic Sales Volume by Application (2018-2023)
3.3 Oral Sales, Revenue and Growth Rate (2018-2023)
3.4 Parenteral Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Ankylosing Spondylitis Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Ankylosing Spondylitis Industry News
4.7.2 Ankylosing Spondylitis Industry Policies

5 Global Ankylosing Spondylitis Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Ankylosing Spondylitis Sales Volume by Region (2018-2023)
5.2 Global Ankylosing Spondylitis Market Revenue ($) by Region (2018-2023)

6 Global Ankylosing Spondylitis Import Volume and Export Volume by Major Regions
6.1 Global Ankylosing Spondylitis Import Volume by Region (2018-2023)
6.2 Global Ankylosing Spondylitis Export Volume by Region (2018-2023)

7 North America Ankylosing Spondylitis Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
7.2 North America Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
7.3 North America Ankylosing Spondylitis Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Ankylosing Spondylitis Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Ankylosing Spondylitis Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)

9 Europe Ankylosing Spondylitis Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
9.2 Europe Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
9.3 Europe Ankylosing Spondylitis Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)

10 Latin America Ankylosing Spondylitis Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
10.3 Latin America Ankylosing Spondylitis Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Ankylosing Spondylitis Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Ankylosing Spondylitis Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Ankylosing Spondylitis Revenue ($) and Market Share of Key Players
12.1.2 Global Ankylosing Spondylitis Sales Volume and Market Share of Key Players
12.1.3 Global Ankylosing Spondylitis Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Shanghai Pharmaceuticals Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Shanghai Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Pfizer Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Abbvie Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Abbvie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 UCB Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 UCB Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Eisai Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Eisai Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Celgene Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Celgene Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Regeneron Pharmaceuticals Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Regeneron Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Merck & Co. Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Merck Sharp & Dohme Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Merck Sharp & Dohme Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Novartis Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Novartis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Celltrion Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Celltrion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Sanofi Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Bristol-Myers Squibb Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Bristol-Myers Squibb Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Janssen Pharmaceuticals Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Janssen Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 Otsuka Pharmaceutical Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 Otsuka Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 F. Hoffmann-La Roche Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 F. Hoffmann-La Roche Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 Amgen Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 Boehringer Ingelheim Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 Boehringer Ingelheim Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Ankylosing Spondylitis Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Ankylosing Spondylitis
13.3.3 Raw Material Cost of Ankylosing Spondylitis
13.3.4 Labor Cost of Ankylosing Spondylitis
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Ankylosing Spondylitis Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Ankylosing Spondylitis Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Ankylosing Spondylitis Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Ankylosing Spondylitis Sales Volume Forecast by Type (2023-2028)
15.2 Global Ankylosing Spondylitis Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Ankylosing Spondylitis Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Ankylosing Spondylitis Sales Volume Forecast by Application (2023-2028)
15.3 Global Ankylosing Spondylitis Sales Volume Forecast by Region (2023-2028)
15.4 Global Ankylosing Spondylitis Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Ankylosing Spondylitis Picture
Table Ankylosing Spondylitis Definition
Table Description and Definitions
Figure TNF Inhibitors Features
Figure COX Inhibitors Features
Figure Others Features
Table Description and Definitions
Figure Oral
Figure Parenteral
Figure North America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Europe Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Global Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2028)
Figure Global Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2028)
Table Global Ankylosing Spondylitis Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Ankylosing Spondylitis Historic Revenue ($) Share by Type (2018-2023)
Table Global Ankylosing Spondylitis Historic Sales Volume by Type (2018-2023)
Table Global Ankylosing Spondylitis Historic Sales Volume Share by Type (2018-2023)
Figure Global TNF Inhibitors Sales and Growth Rate (2018-2023)
Figure Global TNF Inhibitors Price (2018-2023)
Figure Global COX Inhibitors Sales and Growth Rate (2018-2023)
Figure Global COX Inhibitors Price (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Ankylosing Spondylitis Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Ankylosing Spondylitis Historic Revenue ($) Share by Application (2018-2023)
Table Global Ankylosing Spondylitis Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Ankylosing Spondylitis Historic Sales Volume Share by Application (2018-2023)
Figure Global Oral Sales and Growth Rate (2018-2023)
Figure Global Oral Revenue and Growth Rate (2018-2023)
Figure Global Parenteral Sales and Growth Rate (2018-2023)
Figure Global Parenteral Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Ankylosing Spondylitis Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Ankylosing Spondylitis Sales Volume by Region (2018-2023)
Table Global Ankylosing Spondylitis Sales Volume Share by Region (2018-2023)
Table Global Ankylosing Spondylitis Market Revenue ($) by Region (2018-2023)
Table Global Ankylosing Spondylitis Market Revenue ($) Share by Region (2018-2023)
Table Global Ankylosing Spondylitis Import Volume by Region (2018-2023)
Table Global Ankylosing Spondylitis Export Volume by Region (2018-2023)
Figure North America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure North America Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
Table North America Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
Table North America Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Table North America Ankylosing Spondylitis Sales Volume by Country (2018-2023)
Figure United States Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Canada Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
Table Asia Pacific Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Sales Volume by Country (2018-2023)
Figure China Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Japan Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure India Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Figure Australia Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Europe Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Europe Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
Table Europe Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
Table Europe Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Table Europe Ankylosing Spondylitis Sales Volume by Country (2018-2023)
Figure Germany Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure France Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Italy Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Spain Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Russia Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Poland Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
Table Latin America Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
Table Latin America Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Table Latin America Ankylosing Spondylitis Sales Volume by Country (2018-2023)
Figure Mexico Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Ankylosing Spondylitis Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Ankylosing Spondylitis Market Trends Analysis Under Global Inflation
Table Middle East and Africa Ankylosing Spondylitis Revenue ($) by Country (2018-2023)
Table Middle East and Africa Ankylosing Spondylitis Sales Volume by Country (2018-2023)
Figure GCC Countries Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Figure Africa Ankylosing Spondylitis Revenue ($) and Growth Rate (2018-2023)
Table Global Ankylosing Spondylitis Revenue ($) of Key Players (2018-2023)
Table Global Ankylosing Spondylitis Revenue ($) Share of Key Players (2018-2023)
Table Global Ankylosing Spondylitis Sales Volume of Key Players (2018-2023)
Table Global Ankylosing Spondylitis Sales Volume Share of Key Players (2018-2023)
Table Global Ankylosing Spondylitis Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Shanghai Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Shanghai Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Shanghai Pharmaceuticals Production and Growth Rate
Figure Shanghai Pharmaceuticals Value ($) Market Share 2018-2023
Table Pfizer Company Profiles
Table Product Profiles and Application
Table Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Abbvie Company Profiles
Table Product Profiles and Application
Table Abbvie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Abbvie Production and Growth Rate
Figure Abbvie Value ($) Market Share 2018-2023
Table UCB Company Profiles
Table Product Profiles and Application
Table UCB Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure UCB Production and Growth Rate
Figure UCB Value ($) Market Share 2018-2023
Table Eisai Company Profiles
Table Product Profiles and Application
Table Eisai Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Eisai Production and Growth Rate
Figure Eisai Value ($) Market Share 2018-2023
Table Celgene Company Profiles
Table Product Profiles and Application
Table Celgene Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2018-2023
Table Regeneron Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Regeneron Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Regeneron Pharmaceuticals Production and Growth Rate
Figure Regeneron Pharmaceuticals Value ($) Market Share 2018-2023
Table Merck & Co. Company Profiles
Table Product Profiles and Application
Table Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2018-2023
Table Merck Sharp & Dohme Company Profiles
Table Product Profiles and Application
Table Merck Sharp & Dohme Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck Sharp & Dohme Production and Growth Rate
Figure Merck Sharp & Dohme Value ($) Market Share 2018-2023
Table Novartis Company Profiles
Table Product Profiles and Application
Table Novartis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2018-2023
Table Celltrion Company Profiles
Table Product Profiles and Application
Table Celltrion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2018-2023
Table Sanofi Company Profiles
Table Product Profiles and Application
Table Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2018-2023
Table Bristol-Myers Squibb Company Profiles
Table Product Profiles and Application
Table Bristol-Myers Squibb Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2018-2023
Table Janssen Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Janssen Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Janssen Pharmaceuticals Production and Growth Rate
Figure Janssen Pharmaceuticals Value ($) Market Share 2018-2023
Table Otsuka Pharmaceutical Company Profiles
Table Product Profiles and Application
Table Otsuka Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Otsuka Pharmaceutical Production and Growth Rate
Figure Otsuka Pharmaceutical Value ($) Market Share 2018-2023
Table F. Hoffmann-La Roche Company Profiles
Table Product Profiles and Application
Table F. Hoffmann-La Roche Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure F. Hoffmann-La Roche Production and Growth Rate
Figure F. Hoffmann-La Roche Value ($) Market Share 2018-2023
Table Amgen Company Profiles
Table Product Profiles and Application
Table Amgen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2018-2023
Table Boehringer Ingelheim Company Profiles
Table Product Profiles and Application
Table Boehringer Ingelheim Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Ankylosing Spondylitis
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Ankylosing Spondylitis with Contact Information
Figure Production Process of Ankylosing Spondylitis
Figure Manufacturing Cost Structure of Ankylosing Spondylitis
Table Major Distributors of Ankylosing Spondylitis with Contact Information
Table Major Downstream Buyers of Ankylosing Spondylitis with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Ankylosing Spondylitis Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Ankylosing Spondylitis Revenue ($) Share Forecast by Type (2023-2028)
Table Global Ankylosing Spondylitis Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Ankylosing Spondylitis Sales Volume Share Forecast by Type (2023-2028)
Table Global Ankylosing Spondylitis Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Ankylosing Spondylitis Revenue ($) Share Forecast by Application (2023-2028)
Table Global Ankylosing Spondylitis Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Ankylosing Spondylitis Sales Volume Share Forecast by Application (2023-2028)
Table Global Ankylosing Spondylitis Sales Volume Forecast by Region (2023-2028)
Table Global Ankylosing Spondylitis Sales Volume Share Forecast by Region (2023-2028)
Table Global Ankylosing Spondylitis Revenue ($) Forecast by Region (2023-2028)
Table Global Ankylosing Spondylitis Revenue ($) Share Forecast by Region (2023-2028)
  • Global Ankylosing Spondylitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Ankylosing Spondylitis market: According to our latest research, the global Ankylosing Spondylitis market looks promising in the next 5 years. As of 2022, the global Ankylosing Spondylitis market was estimated at USD 5633.32 million, and it's anticipated to reach USD 9003.47 million in 2028, with a CAGR of 8.13% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Osteoarthritis Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Osteoarthritis Treatment market: According to our latest research, the global Osteoarthritis Treatment market looks promising in the next 5 years. As of 2022, the global Osteoarthritis Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Viscosupplementation Market Research Report 2023
    Published: 11-Oct-2023        Price: US 2900 Onwards        Pages: 92
    Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms. According to QYResearch's new survey, global Viscosupplementation market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctua......
  • Global Psoriatic Arthritis Market 2023
    Published: 01-Sep-2023        Price: US 3350 Onwards        Pages: 91
    Description The global market for psoriatic arthritis treatment is projected to reach USD 12.72 billion by 2029, growing at a CAGR of 6.1% from USD 8.27 billion in 2022. Psoriatic arthritis is a chronic inflammatory rheumatic disease that affects up to 30% of psoriasis patients aged 30 to 60. It is more common in women. The exact cause is unknown, but family history and certain risk factors play a role. Diagnosis involves imaging techniques and symptom evaluation. Treatment options include......
  • Global Tinea Pedis Treatment Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 114
    Fungal foot-animal, known medically as tinea pedis, is a common skin infection of the feet caused by fungus. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. In this report, we study the drugs for Fungal foot-animal. The global Tinea Pedis Treatment market is projected to grow from US$ 1230 million in 2023 to US$ 1520.8 mi......
  • Global Osteoarthritis Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 10-Aug-2023        Price: US 3260 Onwards        Pages: 100
    The Osteoarthritis Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Osteoarthritis Treatment industry, and breaks down according to the type, application, and consumption area of Osteoarthritis Treatment. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Osteoarthritis Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Aug-2023        Price: US 3260 Onwards        Pages: 102
    The Osteoarthritis market revenue was 7668.26 Million USD in 2022, and will reach 14182.81 Million USD in 2028, with a CAGR of 10.79% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Osteoarthritis industry, and breaks down according to the type, application, and consumption area of Osteoarthritis. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes......
  • Global Viscosupplementation Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jul-2023        Price: US 3260 Onwards        Pages: 104
    The Viscosupplementation market revenue was 2579.17 Million USD in 2022, and will reach 3483.24 Million USD in 2028, with a CAGR of 5.14% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Viscosupplementation industry, and breaks down according to the type, application, and consumption area of Viscosupplementation. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Ankylosing Spondylitis Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 99
    The Ankylosing Spondylitis market revenue was 5633.32 Million USD in 2022, and will reach 9003.47 Million USD in 2028, with a CAGR of 8.13% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Ankylosing Spondylitis industry, and breaks down according to the type, application, and consumption area of Ankylosing Spondylitis. The report also introduces players in the industry from the perspective of the industry chain and marketi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs